Amivantamab plus lazertinib in previously untreated EGFR-mutated advanced NSCLC - Cho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; et al. (The New England journal of medicine, 2024)
Gesehen am 05.03.2025